KRT19 and neoplasm: Serum tumor markers (TMs) have long been considered metabolites of tumor tissue, including carcinoembryonic antigen (CEA), carbohydrate antigens (CA125, CA15-3, and CA19-9), cytokeratin-19-fragment (CYFRA21-1) and neuron-specific enolase (NSE).